Rheumatoid arthritis treatment Archives | Page 2 of 10 | Rheumatoid Arthritis Warrior

Rheumatoid Arthritis (RA) Treat to Target

The treat to target (T2T) approach involves defining a treatment goal or “target” and modifying the therapy if the target is not reached. Treating to a target of remission or low disease activity Treat to target (T2T) is an approach to treating Rheumatoid Arthritis / Rheumatoid Disease (RD) that combines aggressive or intensive treatment with disease modifying...Continue reading      2 Comments » Read more

News on Biosimilar Biologics for Rheumatoid Arthritis / Rheumatoid Disease

Little progress on FDA path of biosimilar biologics for RD It’s hard to believe it’s been almost two years since we’ve discussed biosimilars on Rheumatoid Arthritis Warrior (RAW). What’s even harder to believe: the situation in the U.S. is much the same: 1) The Biologics Price Competition and Innovation Act (BPCI) was created as a pathway for...Continue reading      1 Comment » Read more

Levels of Treatment Response in Rheumatoid Arthritis

<<Back to Toolkit for RD care page “Present treatment strategies for rheumatoid arthritis include use of disease-modifying antirheumatic drugs, but a minority of patients achieve a good response.”[1] Most of what people know about treatments for Rheumatoid Disease has been communicated by pharmaceutical companies through drug reps, or in press releases or direct to consumer advertisements. The...Continue reading      Make a Comment » Read more

New Rheumatoid Arthritis Treatments in the Research Pipeline

New RA Medications in Development MORE INFORMATION ON CLINICAL TRIALS IN PROCESS: Listing by state of all clinical trials for Rheumatoid Arthritis in the US that are currently recruiting volunteers. Abbreviations: IV (intravenous), sub-Q (subcutaneous injection), mAb (monoclonal antibody), IL (interleukin) NOTE: Agents that stopped development or that did not report after trial completion are omitted. Listing is alphabetical...Continue reading      Comments Off on New Rheumatoid Arthritis Treatments in the Research Pipeline Read more

Rheumatoid Arthritis Treatments

List of disease-modifying anti-rheumatic drugs (DMARDs) used for Rheumatoid Arthritis List of biologics used for treatment of Rheumatoid Arthritis List of less-commonly used DMARDs for Rheumatoid Arthritis Common Rheumatoid Arthritis Medications     [table caption="Disease-modifying anti-rheumatic drugs (DMARDs) used for RA" width="500" colwidth="20|100|50" colalign="left|left|center|left|right"] US Brand name,Manufacturer,Generic name,Administration method,Dose schedule,Mode of action Arava,Sanofi-Aventis,leflunomide,oral,daily,inhibits a specific mitochondrial enzyme Azulfidine,Pfizer,sulfasalazine,oral,twice a day,immune suppression through IL-1...Continue reading      Make a Comment » Read more

7 Key Facts on Rheumatoid Arthritis Medications

<< Go to more FACTS and INFO on Rheumatoid Arthritis IMPORTANT INFO on RA MEDICATIONS    Click here to print or save 7 Key Facts on RA Medications. 1.  There is wide variation in response rates to current Rheumatoid Arthritis treatments. Medications are effective at reducing symptoms or slowing progression of damage in a minority of patients with moderate...Continue reading      Comments Off on 7 Key Facts on Rheumatoid Arthritis Medications Read more
Would You Like Free Email Updates?
Stay in touch with RA Warrior.
We respect your privacy. Your email address will never be shared.